{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:45:16Z","timestamp":1791895516833,"version":"4.3.4"},"reference-count":53,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,6,11]],"date-time":"2009-06-11T00:00:00Z","timestamp":1244678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p>Beta\u2010blockers were documented to reduce reinfarction rate more than 3\u2003decades ago and subsequently touted as being cardioprotective for a broad spectrum of cardiovascular indications such as hypertension, diabetes, angina, atrial fibrillation as well as perioperatively in patients undergoing surgery. However, despite lowering blood pressure, beta\u2010blockers have never shown to reduce morbidity and mortality in uncomplicated hypertension. Also, beta\u2010blockers do not prevent heart failure in hypertension any better than any other antihypertensive drug class. Beta\u2010blockers have been shown to increase the risk on new onset diabetes. When compared with nondiuretic antihypertensive drugs, beta\u2010blockers increase all\u2010cause mortality by 8% and stroke by 30% in patients with new onset diabetes. Beta\u2010blockers are useful for rate control in patients with chronic atrial fibrillation but do not help restore sinus rhythm or have antifibrillatory effects in the atria. Beta\u2010blockers provide symptomatic relief in patients with chronic stable angina but do not reduce the risk of myocardial infarction. Adverse effects of beta\u2010blockers are common including fatigue, dizziness, depression and sexual dysfunction. However, beta\u2010blockers remain a cornerstone in the management of patients having suffered a myocardial infarction and for patients with heart failure. Thus, recent evidence argues against universal cardioprotective properties of beta\u2010blockers but attest to their usefulness for specific cardiovascular indications.<\/jats:p>","DOI":"10.1111\/j.1365-2796.2009.02140.x","type":"journal-article","created":{"date-parts":[[2009,6,11]],"date-time":"2009-06-11T11:01:59Z","timestamp":1244718119000},"page":"232-241","source":"Crossref","is-referenced-by-count":32,"title":["Cardioprotection with beta\u2010blockers: myths, facts and Pascal\u2019s wager"],"prefix":"10.1111","volume":"266","author":[{"given":"F. H.","family":"Messerli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bangalore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S.","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,8,11]]},"reference":[{"key":"e_1_2_13_2_2","unstructured":"KennedyJohn F. (1962). Commencement address. Speech presented at Yale University New Haven CT USA."},{"key":"e_1_2_13_3_2","unstructured":"OrwellS AngusI.The Collected Essays Journalism and Letters of George Orwell Vol. 3 1968."},{"key":"e_1_2_13_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470693926.ch15"},{"key":"e_1_2_13_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.23.1903"},{"key":"e_1_2_13_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67573-3"},{"key":"e_1_2_13_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002003.pub2"},{"key":"e_1_2_13_8_2","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","article-title":"The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"157","author":"JNC 6. National High Blood Pressure Education Program","year":"1997","journal-title":"Arch Intern Med"},{"key":"e_1_2_13_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92589-T"},{"key":"e_1_2_13_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.293.6555.1145"},{"key":"e_1_2_13_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2007.06492.x"},{"key":"e_1_2_13_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.09.001"},{"key":"e_1_2_13_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.176009"},{"key":"e_1_2_13_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.176009"},{"key":"e_1_2_13_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706780"},{"key":"e_1_2_13_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.20.2313"},{"key":"e_1_2_13_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi190"},{"key":"e_1_2_13_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(86)90888-X"},{"key":"e_1_2_13_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl259"},{"key":"e_1_2_13_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.06.048"},{"key":"e_1_2_13_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61299-9"},{"key":"e_1_2_13_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.606962"},{"key":"e_1_2_13_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.553370"},{"key":"e_1_2_13_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.05.057"},{"key":"e_1_2_13_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003303421301"},{"key":"e_1_2_13_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.05.057"},{"key":"e_1_2_13_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60108-1"},{"key":"e_1_2_13_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000125726.92964.ab"},{"key":"e_1_2_13_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.33.5.1130"},{"key":"e_1_2_13_30_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-5-200503010-00006"},{"key":"e_1_2_13_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328122dd58"},{"key":"e_1_2_13_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.106.085654"},{"key":"e_1_2_13_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.08.059"},{"key":"e_1_2_13_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.695007"},{"key":"e_1_2_13_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00595-1"},{"key":"e_1_2_13_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00789-4"},{"key":"e_1_2_13_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01540-6"},{"key":"e_1_2_13_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90284-1"},{"key":"e_1_2_13_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.07.018"},{"key":"e_1_2_13_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00693-8"},{"key":"e_1_2_13_41_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-12-200112180-00010"},{"key":"e_1_2_13_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.10.043"},{"key":"e_1_2_13_43_2","volume-title":"Atrial Fibrillation after Cardiac Surgery","author":"Steinberg JS","year":"1999"},{"key":"e_1_2_13_44_2","first-page":"1720","volume-title":"JAMA","author":"Mathew JP","year":"2004"},{"key":"e_1_2_13_45_2","unstructured":"GibbonsRJ AbramsJ ChatterjeeKet\u00a0al.ACC\/AHA 2002 guideline update for the management of patients with chronic stable angina.2002Available at:http:\/\/www.acc.org\/qualityandscience\/clinical\/statements.htm"},{"key":"e_1_2_13_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl001"},{"key":"e_1_2_13_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(76)90293-9"},{"key":"e_1_2_13_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.40.9.998"},{"key":"e_1_2_13_49_2","unstructured":"Lancet 1986 2 Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS\u20101"},{"key":"e_1_2_13_50_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7200.1730"},{"key":"e_1_2_13_51_2","unstructured":"PascalBlaise(composed in 1600s first published in 1800s)Pensees section 343; translated & reprinted by Penguin and many others."},{"key":"e_1_2_13_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60601-7"},{"key":"e_1_2_13_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67661-1"},{"key":"e_1_2_13_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61560-3"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2009.02140.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2796.2009.02140.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T07:32:23Z","timestamp":1697095943000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2009.02140.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,11]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1365-2796.2009.02140.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2009.02140.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,11]]}}}